Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Vrdn-003, Autoinjector
Thyroid Eye Disease
Phase III
Recruiting
A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Aug 07, 2025
―
Vrdn-003
Thyroid Eye Disease (Ted)
Phase III
Recruiting
A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Jan 27, 2025
―
Vrdn-003
Thyroid Eye Disease
Phase III
Active Not Recruiting
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)
Oct 01, 2024
―
Vrdn-003
Thyroid Eye Disease
Phase III
Active Not Recruiting
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)
Oct 01, 2024
―
Vrdn-001 10 Mg/Kg, Vrdn-001 3 Mg/Kg
Thyroid Eye Disease
Phase III
Active Not Recruiting
A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)
Apr 22, 2024
―
Intervention/Treatment
Thyroid Eye Disease
Phase III
Completed
An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301
Dec 12, 2023
―
Veligrotug (Vrdn-001)
Thyroid Eye Disease
Phase III
Completed
An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)
Aug 25, 2023
―
Vrdn-001 Phase 3 Cohort (Thrive)
Thyroid Eye Disease
Phase III
Completed
A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE )
Dec 15, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Viridian Therapeutics (VRDN) have in its pipeline
VRDN is currently developing the following drugs: Vrdn-003, Autoinjector, Vrdn-003, Vrdn-003. These drug candidates are in various stages of clinical development as the company works toward FDA approval.